Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirin

被引:3
|
作者
Grande, L.
Madrazo, A.
Viloria, M. M.
Nogales, M. C.
Corpas, R.
Camacho, I.
Sanchez-Munoz, D.
Martin-Mazuelos, E.
Romero-Gomez, M.
机构
[1] UCM Digest Dis, Madrid, Spain
[2] Hosp Univ Valme, Microbiol Unit, Seville, Spain
[3] Hosp Univ Valme, Biochem Unit, Seville, Spain
关键词
D O I
10.1016/S0168-8278(07)62236-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
638
引用
收藏
页码:S241 / S241
页数:1
相关论文
共 50 条
  • [31] Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Chern
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 712 - 718
  • [32] Ketoprofen,peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C:A phaseⅡ study
    Annagiulia Gramenzi
    Carmela Cursaro
    Marzia Margotti
    Clara Balsano
    Alessandra Spaziani
    Simona Anticoli
    Elisabetta Loggi
    Maddalena Salerno
    Silvia Galli
    Giuliano Furlini
    Mauro Bernardi
    Pietro Andreone
    World Journal of Gastroenterology, 2009, 15 (47) : 5946 - 5952
  • [33] ADHERENCE RATES FOR PEGINTERFERON plus RIBAVIRIN COMPARED WITH TELAPREVIR plus PEGINTERFERON plus RIBAVIRIN IN MEDICAID AND COMMERCIAL PATIENTS TREATED FOR CHRONIC HEPATITIS C
    Samp, J. C.
    Walker, D.
    Manthena, S.
    Juday, T.
    VALUE IN HEALTH, 2014, 17 (07) : A368 - A368
  • [34] SPLIT 24 WEEKS TREATMENT COURSE OF PEGINTERFERON PLUS RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C
    Park, Jun Yong
    Yoon, Ki Tae
    Kim, Mi Na
    Kim, Do Young
    Ahn, Sang Hoon
    Paik, Yong Han
    Lee, Kwan Sik
    Moon, Byung Soo
    Moon, Young Myoung
    Chon, Chae Yoon
    Han, Kwong-Hyub
    HEPATOLOGY, 2008, 48 (04) : 895A - 895A
  • [35] Boceprevir With Peginterferon Alfa-2a-Ribavirin Is Effective for Previously Treated Chronic Hepatitis C Genotype 1 Infection
    Flamm, Steven L.
    Lawitz, Eric
    Jacobson, Ira
    Bourliere, Marc
    Hezode, Christophe
    Vierling, John M.
    Bacon, Bruce R.
    Niederau, Claus
    Sherman, Morris
    Goteti, Venkata
    Sings, Heather L.
    Barnard, Richard O.
    Howe, John A.
    Pedicone, Lisa D.
    Burroughs, Margaret H.
    Brass, Clifford A.
    Albrecht, Janice K.
    Poordad, Fred
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (01) : 81 - U216
  • [36] A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C
    Hara, Tasuku
    Akuta, Norio
    Suzuki, Fumitaka
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (10) : 1746 - 1753
  • [37] Peginterferon alfa-2a and ribavirin in African American and Caucasian patients with chronic hepatitis C, genotype 1
    Conjeevaram, HS
    Fried, MW
    Jeffers, LJ
    Terrault, N
    Wiley-Lucas, TE
    Afdhal, N
    Brown, RS
    Belle, SH
    Robuck, PR
    Howell, CD
    HEPATOLOGY, 2005, 42 (04) : 275A - 276A
  • [39] Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α-2b plus ribavirin
    Chu, C. -J.
    Lee, S. -D.
    Hung, T. -H.
    Lin, H. -C.
    Hwang, S. -J.
    Lee, F. -Y.
    Lu, R. -H.
    Yu, M. -I.
    Chang, C. -Y.
    Yang, P. -L.
    Lee, C. -Y.
    Chang, F. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) : 46 - 54
  • [40] Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
    Hauser, Goran
    Awad, Tahany
    Brok, Jesper
    Thorlund, Kristian
    Stimac, Davor
    Mabrouk, Mahasen
    Gluud, Christian
    Gluud, Lise Lotte
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):